Mark A. F. Kendall (BE PhD FRSA FTSE) (born 1972) is an Australian biomedical engineer, inventor, scientist and entrepreneur.

He is Founder and CEO of WearOptimo Pty Ltd and the Vice-Chancellor's Entrepreneurial Professor at the Australian National University.

Kendall was formerly the Professor of Biomedical Engineering at the University of Queensland, where he led a team at the Australian Institute for Bioengineering and Nanotechnology. He was Founder, CTO and a Director of Vaxxas. Prior to this, in the UK, he was a University Research Lecturer at the University of Oxford and a lecturer at Magdalen College, Oxford. Whilst at Oxford, Kendall was Associate Director of the PowderJect Research Centre for Gene and Drug Delivery.

Kendall serves at the co-chair of the $150 million Australian Stem Cell Therapies Mission^[3] and on the World Economic Forum Global Future Council on Biotechnology.